loader image
Saturday, November 22, 2025
76.8 F
McAllen
- Advertisement -

CPRIT awards $2.5 million to help support cancer research

Translate to Spanish or other 102 languages!

Left to right: Dr. Meena Jaggi, professor, Dr. Subhash Chauhan, professor and chair of the department, and Dr. Murali M. Yallapu, associate professor. UTRGV Photo

Mega Doctor News

- Advertisement -

By Maria Gonzalez 

RIO GRANDE VALLEY, TX – UTRGV has received its first CPRIT grant – $2.5 million in funding for an Integrated Cancer Research Core facility that will serve as a foundation for building the Rio Grande Valley’s growing cancer research network. 

The core also will support the established South Texas Center of Excellence in Cancer Research to address disproportionate, cancer-related health issues in the area. 

- Advertisement -

Dr. Michael B. Hocker, dean of the UTRGV School of Medicine, said the CPRIT grant is extremely competitive.  

“To have been its recipient solidifies UTRGV’s commitment to providing better healthcare options across the Rio Grande Valley,” he said.  

Dr. Subhash Chauhan, Ph.D., professor and chair of the Department of Immunology and Microbiology at the UTRGV School of Medicine, is founding director of the South Texas Center of Excellence in Cancer Research.    “We are thrilled and excited to receive this CPRIT funding for the first time, and it will allow us to bring UTRGV and the Valley to the forefront for our cancer research efforts,” Chauhan said.  

He said it will help support UTRGV’s developing role in fast-track cancer research in the state and place UTRGV researchers at the forefront of significant contributions in new, collaborative research projects. 

- Advertisement -

“With the help of this funding, our cancer researchers will be able to conduct very sophisticated experiments and will be able to develop newer cancer prevention strategies,” Chauhan said.  

The grant will help fund two major pieces of high-tech, state-of-the-art equipment critical in the university’s cancer research.  

“These new instruments will allow researchers to conduct experiments related to cancer imaging in small-animal flow cytometry analysis in a single cell, along with cellular imaging,” Chauhan said.  The Integrated Cancer Research Core facility will serve as a critical location for researchers’ work with local cancer patient samples.  

Hocker said the grant will contribute to UTRGV’s promise to transform the medical landscape in the region.

“This grant is going to help us reach those who seek essential cancer treatment without the need to travel out of the area,” he said. “It’s monumental.”  

Chauhan said UTRGV’s research collaborators play a critical role in this grant project.  

“I am highly thankful to our whole cancer research team, especially Dr. Meena Jaggi and Dr. Murali M. Yallapu, who are key players in this grant,” he said. “Both of these individuals will act as directors of the CPRIT-funded Integrated Cancer Research Core.”   “As an emerging cancer research group, we came up with a theme that has potential to revolutionize the landscape of cancer research in the Valley,” Chauhan said.  

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Current Heart Attack Screening Tools Are Not Optimal and Fail to Identify Half the People Who Are at Risk

Current cardiac screening tools used to prevent heart attacks fail to identify nearly half of the people who are actually at risk of having one, according to a new study led by Mount Sinai researchers.

UT Health San Antonio Center For Brain Health Celebrates with Ribbon Cutting

University of Texas System and UT San Antonio leaders today hailed “a new era of hope, healing and discovery” for neurological patients and their families with a ribbon-cutting for the UT Health San Antonio Center for Brain Health, a $100 million, 103,000-square-foot facility that will bring specialty care, therapy, diagnostics and research under one ro

Paxton Secures $41.5M from Pfizer & Tris Pharma for Providing Adulterated Drugs to Children

Attorney General Ken Paxton has secured a $41.5 million settlement with Pfizer and Tris Pharma for allegedly providing adulterated pharmaceutical drugs to Texas children in violation of the Texas Health Care Program Fraud Prevention Act (“THFPA”).    

STHS’ South Texas Healthy Living Episode on Diabetes Awareness, Nov. 30th

The United States is experiencing a national health crisis as the incidence of diabetes continues to climb across the country.
- Advertisement -
×